RGNX 最新季度财报
公布日期8/6/2026
实际每股收益(美元)0.43
实际营收(美元)108.02M
本页面提供详细的 Regenxbio Inc 财报数据,包括最新财报、下一次财报发布日期、历史数据及 Regenxbio Inc 财报电话会相关新闻。
| 发布日期 | 报告期末 | 每股收益/预测值 | 营收/预测值 | 每股收益超预期幅度 % | 营收超预期幅度 % |
|---|---|---|---|---|---|
| 8/6/2026 | 06/2026 | 0.43/0.06 | 108.02M/117.13M | 641.26% | -7.78% |
| 5/14/2026 | 03/2026 | -1.72/-1.34 | 6.39M/26.32M | -28.29% | -75.71% |
| 3/5/2026 | 12/2025 | -1.30/-0.96 | 30.34M/36.56M | -35.71% | -17.02% |
| 11/6/2025 | 09/2025 | -1.20/-1.31 | 29.73M/24.13M | 8.21% | 23.25% |
| 8/7/2025 | 06/2025 | -1.38/-1.10 | 21.36M/28.11M | -25.14% | -24.02% |
| 5/12/2025 | 03/2025 | 0.12/0.48 | 89.01M/101.97M | -75.47% | -12.71% |
| 3/13/2025 | 12/2024 | -1.01/-1.15 | 21.21M/23.75M | 12.27% | -10.69% |
| 11/6/2024 | 09/2024 | -1.17/-1.12 | 24.20M/23.59M | -4.54% | 2.58% |